Search Results

Immunotherapeutics in the Treatment of Chronic Hepatitis B - S. Browne, MD

Immunotherapeutics in the Treatment of Chronic Hepatitis B - S. Browne, MD

HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci.

HBV Immunotherapeutic Vaccines (Lessons from HCV) - E. Barnes, PhD, FRCP, F. Med. Sci.

New Data From Combination Trials for Chronic Hepatitis B - Pietro Lampertico, MD, PhD

New Data From Combination Trials for Chronic Hepatitis B - Pietro Lampertico, MD, PhD

Hepatitis B (HBV): Presentation by Prof. Dr. Dr. med. Nasser Semmo

Hepatitis B (HBV): Presentation by Prof. Dr. Dr. med. Nasser Semmo

HBV therapy & Approaches to Cure | Jordan Feld, MD, MPH

HBV therapy & Approaches to Cure | Jordan Feld, MD, MPH

Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MD

Update on the Efficacy and Safety of Bulevirtide for Treatment of Chronic HDV - D. Manuilov, MD

STOP Agents - M. McClure, MD

STOP Agents - M. McClure, MD

Immunology of HBV | Adam Gehring, PhD

Immunology of HBV | Adam Gehring, PhD

Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MD

Active Site Polymerase Inhibitor Nucleotides (APSINs) - D. Mayers, MD

Core Inhibitors (Capsid Assembly Modulators) - L. Stamm, MD, PhD

Core Inhibitors (Capsid Assembly Modulators) - L. Stamm, MD, PhD

IMMUNOTHERAPY IN HEPATITIS B

IMMUNOTHERAPY IN HEPATITIS B

Safety Monitoring during HBV Clinical Trials and after Antiviral Discontinuation -P. Mishra, MD

Safety Monitoring during HBV Clinical Trials and after Antiviral Discontinuation -P. Mishra, MD